Anika Therapeutics to issue Q2FY26 results on July 29
Anika Therapeutics, Inc. will announce its Q2FY26 financial results on July 29, 2026, followed by a conference call. The call will be accessible via phone and webcast, with materials available on the company's website.
*this image is generated using AI for illustrative purposes only.
Anika Therapeutics, Inc. will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The company will host a conference call at 8:30 a.m. ET to discuss its results and business highlights.
Conference Call Details
Investors can access the call by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com . The call will be archived and accessible on the same website shortly after its conclusion.
About Anika Therapeutics
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global joint preservation company focused on early intervention orthopedics. The company leverages its expertise in hyaluronic acid and implant solutions to provide minimally invasive products. Its key focus areas include Osteoarthritis Pain Management and Regenerative Solutions, with products delivered in sites of care such as ambulatory surgery centers. Anika's global operations are headquartered outside of Boston, Massachusetts.
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might Anika's focus on early intervention orthopedics influence its market position by late 2026?
What potential regulatory or market challenges could impact Anika's hyaluronic acid-based products?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
